Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Parkinson disease”

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)Recruiting
NCT06780085Phase 2Updated Jul 6, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Non-Small-Cell Lung
United States, Chile, Germany, Greece, Hungary +5 more
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)Recruiting
NCT06961006Phase 2Updated Jul 2, 2026
Sponsor: Merck Sharp & Dohme LLC
Malignant Melanoma
United States, Australia, Canada, France, Germany +7 more
A Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's DiseaseNot Yet Recruiting
NCT07647614Phase 2Updated Jul 2, 2026
Sponsor: Energenesis Biomedical Co., Ltd.
Parkinson's Disease (PD)
Taiwan
Pathways Mediating Impaired Postural Control in Parkinson's DiseaseRecruiting
NCT06464029N/AUpdated Jul 2, 2026
Sponsor: University of Minnesota
Parkinson Disease
United States
The Effect of Bottle PEP Exercise on Expiratory Muscle Thickness, Strength, and Balance Parameters in Parkinson's Disease PatientsRecruiting
NCT07680725N/AUpdated Jul 2, 2026
Sponsor: Marmara University
Parkinson Disease (PD)
Turkey (Türkiye)
Sonification Techniques for Gait TrainingRecruiting
NCT04876339NAUpdated Jul 2, 2026
Sponsor: Istituti Clinici Scientifici Maugeri SpA
Parkinson Disease · Stroke · Multiple Sclerosis
Italy
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008).Active Not Recruiting
NCT04895722Phase 2Updated Jul 2, 2026
Sponsor: Merck Sharp & Dohme LLC
Colorectal Cancer
United States, Belgium, Canada, Colombia, Costa Rica +17 more
Support for Physical Activity in Everyday Life With Parkinson's DiseaseCompleted
NCT05510739NAUpdated Jul 2, 2026
Sponsor: Stiftelsen Stockholms Sjukhem
Parkinson Disease · Physical Activity · eHealth · Gait Disorders, Neurologic
Sweden
Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept NeurostimulatorRecruiting
NCT07682311NAUpdated Jul 2, 2026
Sponsor: University of California, San Francisco
PD - Parkinson's Disease
United States
Probing Gut-Brain Communication in Parkinson's DiseaseNot Yet Recruiting
NCT07673146NAUpdated Jul 2, 2026
Sponsor: Spaulding Rehabilitation Hospital
Parkinson Disease (PD)
Physiological Investigations of Movement DisordersCompleted
NCT01019343NAUpdated Jul 2, 2026
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Parkinson's Disease · Tourette's Syndrome · Tic Disorders · Dystonia
United States
A Long-Term Follow-up Study of the Severe Parkinson's Disease Patients Administered the IPS101A Gene Therapy Product.Recruiting
NCT07629115N/AUpdated Jul 1, 2026
Sponsor: Innopeutics Corporation
Parkinson Disease · Parkinson's Disease
South Korea
Validation of a Novel Functional Food Designed to Meet the Nutritional Needs of People Living With Parkinson's DiseaseActive Not Recruiting
NCT06697626NAUpdated Jul 1, 2026
Sponsor: University of Ulster
Constipation · Parkinson Disease
United Kingdom
Integrated Digital and Neurogenic Exosome Biomarkers for Early Diagnosis of Parkinson's Disease: Development and ApplicationRecruiting
NCT07679256N/AUpdated Jul 1, 2026
Sponsor: Fujian Medical University Union Hospital
PARKINSON DISEASE (Disorder)
China
18F-mFBG Cardiac Uptake With Lewy Body DementiaRecruiting
NCT07176286Phase 2Updated Jul 1, 2026
Sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Parkinson Disease (PD) · Lewy Body Dementia (LBD)
United States
Enhancing Gait Using Alternating-Frequency DBS in Parkinson DiseaseActive Not Recruiting
NCT05022147Phase 1Updated Jul 1, 2026
Sponsor: James Liao
Parkinson Disease · Gait Disorders, Neurologic · Disease Progression · Subthalamic Nucleus
United States
Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's DiseaseRecruiting
NCT05901818Phase 1Updated Jul 1, 2026
Sponsor: Xuanwu Hospital, Beijing
Parkinson's Disease
China
The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Depression in PDNot Yet Recruiting
NCT07679529NAUpdated Jul 1, 2026
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Parkinson Disease
Testing of an Interface for Synchronizing tACS-DBS With a Phase-locked-loopCompleted
NCT07139093NAUpdated Jun 30, 2026
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Deep Brain Stimulation · Parkinson's Disease (PD)
Germany
A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSARecruiting
NCT07604116Phase 1Updated Jun 30, 2026
Sponsor: Synusight Biotech (Shanghai) Co., Ltd.
Multiple System Atrophy (MSA) · Parkinson's Disease (PD)
China
Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's DiseaseActive Not Recruiting
NCT05931575Phase 2Updated Jun 30, 2026
Sponsor: Technical University of Munich
Idiopathic Parkinson´s Disease
Germany
Validation of cueStim for Reduction of Freezing of Gait in Parkinson's DiseaseNot Yet Recruiting
NCT07675408NAUpdated Jun 30, 2026
Sponsor: Fortis Medical Devices Limited
Parkinson's Disease With Freezing of Gait
United States
Group Drum-Based Music Therapy Intervention for Parkinson's Disease/Huntington's DiseaseCompleted
NCT05157074NAUpdated Jun 30, 2026
Sponsor: Johns Hopkins University
Parkinson Disease · Huntington Disease
United States
Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)Completed
NCT04740307Phase 2Updated Jun 30, 2026
Sponsor: Merck Sharp & Dohme LLC
Advanced Hepatocellular Carcinoma
United States, China, Italy, Japan, Poland +4 more
Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersRecruiting
NCT07570212NAUpdated Jun 29, 2026
Sponsor: Peking University First Hospital
Parkinson's Disease · Multiple System Atrophy · Progressive Supranuclear Palsy
China

Previous page Next page